A detailed history of Cypress Capital, LLC transactions in Usana Health Sciences Inc stock. As of the latest transaction made, Cypress Capital, LLC holds 8,262 shares of USNA stock, worth $260,170. This represents 0.08% of its overall portfolio holdings.

Number of Shares
8,262
Previous 9,096 9.17%
Holding current value
$260,170
Previous $345 Million 14.03%
% of portfolio
0.08%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

SELL
$33.38 - $41.29 $27,838 - $34,435
-834 Reduced 9.17%
8,262 $297 Million
Q3 2024

Nov 12, 2024

BUY
$36.17 - $47.2 $329,002 - $429,331
9,096 New
9,096 $345 Million
Q2 2024

Aug 22, 2024

SELL
$41.52 - $49.77 $32,551 - $39,019
-784 Reduced 7.67%
9,434 $426,000
Q1 2024

Oct 29, 2024

BUY
$46.43 - $54.45 $484,079 - $567,695
10,426 New
10,426 $505,000
Q4 2023

Feb 05, 2024

SELL
$44.44 - $58.87 $18,709 - $24,784
-421 Reduced 3.96%
10,218 $547,000
Q3 2023

Nov 09, 2023

SELL
$57.94 - $67.92 $93,225 - $109,283
-1,609 Reduced 13.14%
10,639 $623,000
Q2 2023

Aug 07, 2023

BUY
$60.41 - $67.9 $1,268 - $1,425
21 Added 0.17%
12,248 $772,000
Q1 2023

Apr 27, 2023

SELL
$54.42 - $63.48 $19,482 - $22,725
-358 Reduced 2.84%
12,227 $769,000
Q4 2022

Feb 01, 2023

SELL
$48.66 - $59.68 $2,238 - $2,745
-46 Reduced 0.36%
12,585 $669,000
Q3 2022

Feb 01, 2023

SELL
$56.05 - $76.51 $48,819 - $66,640
-871 Reduced 6.45%
12,631 $707,000
Q2 2022

Aug 04, 2022

SELL
$68.28 - $82.87 $11,949 - $14,502
-175 Reduced 1.28%
13,502 $977,000
Q1 2022

May 09, 2022

BUY
$77.82 - $102.94 $100,387 - $132,792
1,290 Added 10.41%
13,677 $1.09 Million
Q4 2021

Feb 10, 2022

SELL
$92.48 - $103.74 $160,360 - $179,885
-1,734 Reduced 12.28%
12,387 $1.25 Million
Q3 2021

Feb 10, 2022

BUY
$87.4 - $102.73 $21,850 - $25,682
250 Added 1.8%
14,121 $1.3 Million
Q2 2021

Aug 16, 2021

SELL
$88.8 - $106.45 $8,880 - $10,645
-100 Reduced 0.72%
13,871 $1.42 Million
Q1 2021

May 17, 2021

SELL
$77.95 - $101.39 $17,382 - $22,609
-223 Reduced 1.57%
13,971 $1.36 Million
Q4 2020

Feb 16, 2021

SELL
$73.72 - $85.86 $16,144 - $18,803
-219 Reduced 1.52%
14,194 $1.09 Million
Q3 2020

Nov 12, 2020

SELL
$72.39 - $91.2 $45,026 - $56,726
-622 Reduced 4.14%
14,413 $1.13 Million
Q2 2020

Aug 20, 2020

SELL
$55.29 - $89.22 $101,788 - $164,254
-1,841 Reduced 10.91%
15,035 $1.1 Million
Q4 2019

Feb 10, 2020

SELL
$66.23 - $80.03 $61,328 - $74,107
-926 Reduced 5.2%
16,876 $1.33 Million
Q3 2019

Nov 21, 2019

SELL
$58.92 - $76.74 $98,926 - $128,846
-1,679 Reduced 8.62%
17,802 $1.22 Million
Q2 2019

Jul 11, 2019

SELL
$70.78 - $91.34 $185,655 - $239,584
-2,623 Reduced 11.87%
19,481 $1.55 Million
Q1 2019

May 01, 2019

SELL
$83.3 - $118.97 $227,908 - $325,501
-2,736 Reduced 11.01%
22,104 $1.85 Million
Q4 2018

Feb 14, 2019

BUY
$104.01 - $124.67 $2.58 Million - $3.1 Million
24,840 New
24,840 $2.92 Million

Others Institutions Holding USNA

About USANA HEALTH SCIENCES INC


  • Ticker USNA
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 19,198,300
  • Market Cap $605M
  • Description
  • USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted s...
More about USNA
Track This Portfolio

Track Cypress Capital, LLC Portfolio

Follow Cypress Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital, LLC with notifications on news.